| Expression pattern: |
DN |
| Associated gene: |
TUSC2 |
| Associated microRNA: |
miR-183-5p |
| Biological function: |
Circ-EGFR inhibits glioma cell proliferation, colony formation, migration and invasion, promotes apoptosis, and reduces glioma tumor growth in vivo. |
| Molecular mechanism: |
Circ-EGFR acts as a sponge for miR-183-5p and promotes TUSC2 expression, thereby inhibiting glioma progression via the circ-EGFR/miR-183-5p/TUSC2 axis. |
| Biological pathway or process: |
proliferation (inhibits); migration (inhibits); invasion (inhibits); apoptosis (promotes); ceRNA regulation (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Luciferase Reporter Assay; Western Blot; In Vivo Animal Model; Bioinformatics Analysis |
| Clinical significance: |
Circ-EGFR may be a useful therapeutic target to antagonize glioma progression. |
| Description: |
Circ-EGFR is down-regulated in glioma tissues and glioma cell lines. Functional assays show that circ-EGFR overexpression suppresses proliferation, migration, invasion and tumor growth while promoting apoptosis. Mechanistically, circ-EGFR acts as a miR-183-5p sponge to increase TUSC2 expression, forming a tumor-inhibitory circ-EGFR/miR-183-5p/TUSC2 axis. |
| Confidence score: |
0.6542 |